4.41
-0.33 (-6.87%)
| Previous Close | 4.73 |
| Volume | 111,409 |
| Price / Earnings (Forward) | 18.62 |
| Price / Sales | 1.82 |
| Price / Book | 4.01 |
| 52 Weeks Range |
| Profit Margin | -14.76% |
| Operating Margin (TTM) | -25.30% |
| Diluted EPS (TTM) | -0.370 |
| Quarterly Revenue Growth (YOY) | 0.80% |
| Total Debt/Equity (MRQ) | 116.83% |
| Current Ratio (MRQ) | 1.34 |
| Operating Cash Flow (TTM) | -6.94 M |
| Levered Free Cash Flow (TTM) | -18.74 M |
| Return on Assets (TTM) | -5.70% |
| Return on Equity (TTM) | -48.14% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Journey Medical Corporation | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | -3.0 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.24 |
Select this tab to load the latest available analysis.
|
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Core |
| % Held by Insiders | 30.89% |
| % Held by Institutions | 29.96% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |